Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-02-13
1996-11-19
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
5142312, 514362, 514652, A61K 31135
Patent
active
055763529
ABSTRACT:
The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 2997422 (1961-08-01), Tedeschi et al.
patent: 3551493 (1970-12-01), Ruschig et al.
patent: 3961073 (1976-06-01), Snyder
Chemical Abstracts, Puscas et al., Synergistic drug for the treatment of gastritis, gastroduodenitis and gastroduodenal ucler. 109: 98864. (1988).
Bulbring, E., et. al., Adv. Pharmac., 6A, 323-333 (1968).
Blundell, J. E., Neuropharmacology, 23, 1537-1551 (1984).
Gidda Jaswant S.
Schaus John M.
Demeter John C.
Eli Lilly and Company
Weddington Kevin E.
LandOfFree
Method of inhibiting gastric acid secretion with aryloxypropanol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting gastric acid secretion with aryloxypropanol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting gastric acid secretion with aryloxypropanol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541440